Derek Chalmers, Ph.D., D.Sc.
Chief Executive Officer, President, and Director
Dr. Chalmers is a co-founder and has served as President, Chief Executive Officer and Director of Cara since 2004. Dr. Chalmers has over 22 years’ experience in the biotechnology industry with increasing levels of corporate and business responsibilities. Prior to founding Cara Therapeutics, Inc., Dr. Chalmers co-founded Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), a drug discovery and development company, and served as its Vice President and Executive Director from June 1997 until May 2004. Prior to Arena, Dr. Chalmers was a Group Leader at Neurocrine Biosciences (NASDAQ: NBIX).
Dr. Chalmers holds a Ph.D. from The Wellcome Surgical Institute, University of Glasgow and has previously conducted research as both a NARSAD and Fogerty International Fellow at The University of Michigan.